We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Toxic Sugar Buildup Kills Tuberculosis Bacteria

By LabMedica International staff writers
Posted on 29 Mar 2010
Interrupting the biochemical pathway leading to alpha glucan synthesis in Mycobacterium tuberculosis causes the buildup of a toxic precursor that quickly kills the microorganism.

Investigators at the Albert Einstein College of Medicine (New York, NY, USA) traced a heretofore unrecognized molecular pathway from trehalose to alpha-glucan in M. More...
tuberculosis that comprised four distinct steps mediated in turn by the enzymes TreS, Pep2, GlgE (which was identified as a maltosyltransferase that used maltose 1-phosphate), and GlgB. Alpha glucans are essential for maintaining the structure of the bacterial cell wall, and for generating new microbes through cell division.

The investigators focused their attention on the enzyme GlgE, since there are no enzymes similar to it in humans or in the bacteria of the human gut. As described in their paper published in the March 21, 2010, online issue of the journal Nature Chemical Biology, they used traditional and chemical reverse genetics to show that GlgE inactivation caused rapid death of M. tuberculosis both in vitro and in mice through a self-poisoning accumulation of the precursor maltose 1-phosphate, which damaged bacterial DNA.

"We were amazed when we knocked out GlgE that we saw this DNA damage response,” said senior author Dr. William R. Jacobs, Jr., professor of microbiology, immunology, and genetics at Albert Einstein College of Medicine. "That is usually a very effective way to kill bacteria, when you start damaging the DNA. This approach is totally different from the way any other anti-TB drug works. In the past few years, extremely drug resistant strains of TB have arisen that cannot be eliminated by any drugs, so new strategies for attacking TB are urgently needed.”

Related Links:
Albert Einstein College of Medicine




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.